Impact of COVID-19 pandemic on gastrointestinal cancer diagnosis and resection: An observational study.

ABSTRACT:

Background

The COVID-19 pandemic disrupted routine screening for and treatment of gastrointestinal (GI) cancers. We analyzed changes in GI cancer pathology specimens resulting from diagnostic and therapeutic procedures at a single academic center in an epicenter of the COVID-19 pandemic. Our aim was to determine which cancer types, procedures, and patients were impacted by the pandemic.

Methods

This was a retrospective, cohort study of patients identified based on carcinoma containing pathologic specimens reviewed in our institution resulting from diagnostic or resection procedures. Pathology and medical records of patients with GI and liver carcinoma and high-grade dysplasia were reviewed from February 1 to April 30 in 2018, 2019 and 2020. We used March 16, 2020 to delineat

SUBMITTER: Grinspan LT 

PROVIDER: S-EPMC8608414 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature